Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers-Reference-Cited by-同舟云学术

Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers

Author:

Patel Rajesh¹,Palmer Jonathan L.²,Joshi Shashidhar³,Di Ció Gimena Alejandro⁴,Esquivel Florencia⁴

Affiliation:

1. GlaxoSmithKline; Brentford Middlesex UK

2. GlaxoSmithKline; Uxbridge Middlesex UK

3. GlaxoSmithKline QSI; Bangalore India

4. Laboratorios Phoenix S.A.I.C.F.; Malvinas Argentinas Provincia de Buenos Aires Argentina

Funder

Phoenix

GlaxoSmithKline

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference13 articles.

1. Differential clinical profile of candesartan compared to other angiotension receptor blockers;Cernes;Vasc Health Risk Manag,2011

3. Multisource drug policies in Latin America: survey of 10 countries;Homedes;Bull World Health Organ,2005

4. Provision 3185/99 http://www.anmat.gov.ar/webanmat/Legislacion/Medicamentos/Disposicion_ANMAT_3185-1999.pdf

5. Provision 4788/12 2012 http://www.anmat.gov.ar/webanmat/legislacion/medicamentos/Disposicion_4788-2012.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献